All sectors
Life Science
Who acquires Life Science companies
497 distinct acquirers across 743 recorded transactions, 2014 to 2026. Every buyer below has completed at least one acquisition in this sector.
743
Transactions
2014 to 2026
497
Named acquirers
distinct buyers
17.5x
Median EV/EBITDA
from 21 disclosed
$110m
Median deal size
enterprise value
Most active acquirers
Ranked by number of acquisitions recorded in this sector. A buyer that has done this more than once has a thesis, and a thesis is what makes an approach worth making.
- Ligand Pharmaceuticals11 deals
- Charles River Laboratories International11 deals
- Allergan11 deals
- Merck10 deals
- Horizon Therapeutics7 deals
- Concentra Biosciences6 deals
- Lilly6 deals
- Roche6 deals
Recorded transactions
| Target | Acquirer | Date | Value | EV/EBITDA | EV/Revenue |
|---|---|---|---|---|---|
| BioLife Solutions | Repligen Corporation | 2026-10-06 | $0k | 0.0x | 0.0x |
| TYRVAYA product rights | Harrow | 2026-10-01 | $30m | 0.0x | 0.0x |
| BeyondSpring Ltd. | Biolin Investment Limited | 2026-09-30 | $0k | 0.0x | 0.0x |
| Mantle | Lexeo Therapeutics | 2026-09-29 | $8m | 0.0x | 0.0x |
| Theravance Biopharma | Zymeworks Inc. | 2026-09-23 | $0k | 0.0x | 0.0x |
| Marea Therapeutics | Lisata Therapeutics | 2026-09-17 | $0k | 0.0x | 0.0x |
| Naveris | CareDx | 2026-09-16 | $0k | 0.0x | 0.0x |
| Convergent Genomics Inc. | Veracyte | 2026-09-14 | $150m | 0.0x | 0.0x |
| AtaiBeckley Inc. | Eli Lilly and Company | 2026-09-11 | $0k | 0.0x | 0.0x |
| Barinthus Biotherapeutics plc | Beacon Topco | 2026-09-09 | $0k | 0.0x | 0.0x |
| Quince Therapeutics SpA and AIDE/eDSP assets | Ayma Therapeutics | 2026-09-08 | $450k | 0.0x | 0.0x |
| Alkeus Pharmaceuticals | Tarsus Pharmaceuticals | 2026-09-04 | $0k | 0.0x | 0.0x |
| Apogee Therapeutics | AbbVie Inc. | 2026-09-03 | $0k | 0.0x | 0.0x |
| Crinetics Pharmaceuticals | Vertex Pharmaceuticals Incorporated | 2026-09-01 | $0k | 0.0x | 0.0x |
| Lifeline Cell Technology | American Type Culture Collection | 2026-09-01 | $25m | 0.0x | 0.0x |
| Kashiv BioSciences | Amneal Pharmaceuticals | 2026-08-10 | $0k | 0.0x | 0.0x |
| Cy Biopharma | Ensysce Biosciences | 2026-08-05 | $0k | 0.0x | 0.0x |
| Vidya Therapeutics | Processa Pharmaceuticals | 2026-07-28 | $0k | 0.0x | 0.0x |
| Gravitas Life Sciences | Gravitas Collective Corp. | 2026-07-17 | $4m | 0.0x | 0.0x |
| Kira Pharmaceuticals | Jasper Therapeutics | 2026-07-16 | $0k | 0.0x | 0.0x |
| Catalyst Pharmaceuticals | Angelini Pharma S.p.A. | 2026-07-15 | $0k | 0.0x | 0.0x |
| Nuvalent | GSK plc | 2026-07-15 | $0k | 0.0x | 0.0x |
| XOMA Royalty Corporation | Ligand Pharmaceuticals Incorporated | 2026-07-14 | $739m | 0.0x | 0.0x |
| Edgewise Therapeutics muscular dystrophy program (sevasemten) | Servier | 2026-07-10 | $1.6bn | 0.0x | 0.0x |
| Cumberland Pharmaceuticals branded product portfolio | Apotex Inc. | 2026-07-01 | $100m | 0.0x | 0.0x |
| Aptose Biosciences Inc. | Hanmi Pharmaceuticals Co. Ltd. | 2026-06-30 | $3m | 0.0x | 0.0x |
| MacroGenics GMP manufacturing and CDMO operations | Bora Pharmaceuticals Co. | 2026-06-30 | $123m | 0.0x | 0.0x |
| Centessa Pharmaceuticals plc | Eli Lilly and Company | 2026-06-24 | $0k | 0.0x | 0.0x |
| Azora Therapeutics | Adial Pharmaceuticals | 2026-06-11 | $0k | 0.0x | 0.0x |
| KalVista Pharmaceuticals | Chiesi Farmaceutici S.p.A. | 2026-06-11 | $0k | 0.0x | 0.0x |
| Orphai Therapeutics | Quince Therapeutics | 2026-05-18 | $0k | 0.0x | 0.0x |
| Soleno Therapeutics | Neurocrine Biosciences | 2026-05-18 | $0k | 0.0x | 0.0x |
| Apellis Pharmaceuticals | Biogen Inc. | 2026-05-14 | $0k | 0.0x | 0.0x |
| GPC Commave Holding | Collegium Pharmaceutical | 2026-05-12 | $650m | 0.0x | 0.0x |
| Kezar Life Sciences | Aurinia Pharmaceuticals Inc. | 2026-05-11 | $0k | 0.0x | 0.0x |
| Terns Pharmaceuticals | Merck Sharp & Dohme LLC | 2026-05-05 | $0k | 0.0x | 0.0x |
| Cullgen Inc. | Gyre Therapeutics | 2026-05-04 | $300m | 0.0x | 0.0x |
| Amicus Therapeutics | BioMarin Pharmaceutical Inc. | 2026-04-27 | $4.8bn | 0.0x | 0.0x |
| Day One Biopharmaceuticals | Servier Pharmaceuticals LLC | 2026-04-23 | $0k | 0.0x | 0.0x |
| TELI Pharmaceuticals | Telomir Pharmaceuticals | 2026-04-22 | $0k | 0.0x | 0.0x |
| Assertio INDOCIN | Cosette Pharmaceuticals | 2026-04-08 | $35m | 0.0x | 0.0x |
| Ginkgo Biosecurity | Tower Biosecurity | 2026-04-03 | $0k | 0.0x | 0.0x |
| Corstasis Therapeutics Inc. | Esperion Therapeutics | 2026-04-02 | $75m | 0.0x | 0.0x |
| Oratech Pharma | Lifeward Ltd. | 2026-03-25 | $0k | 0.0x | 0.0x |
| Ignite Proteomics | Aditxt | 2026-03-11 | $36m | 0.0x | 0.0x |
| Ventyx Biosciences | Eli Lilly and Company | 2026-03-04 | $0k | 0.0x | 0.0x |
| RAPT Therapeutics | GSK plc | 2026-03-03 | $0k | 0.0x | 0.0x |
| Avidity Biosciences | Novartis AG | 2026-02-27 | $0k | 0.0x | 0.0x |
| Faeth Therapeutics | Sensei Biotherapeutics | 2026-02-17 | $0k | 0.0x | 0.0x |
| Avadel Pharmaceuticals plc | Alkermes plc | 2026-02-12 | $0k | 0.0x | 0.0x |
| Dynavax Technologies Corporation | Sanofi | 2026-02-10 | $0k | 0.0x | 0.0x |
| BD Biosciences and Diagnostic Solutions business | Waters Corporation | 2026-02-09 | $0k | 0.0x | 0.0x |
| Generation Bio Co. | XOMA Royalty Corporation | 2026-02-09 | $0k | 0.0x | 0.0x |
| Applied Therapeutics | Cycle Group Holdings Limited | 2026-02-03 | $14m | 0.0x | 0.0x |
| SomaLogic | Illumina | 2026-01-30 | $350m | 0.0x | 0.0x |
| Repare Therapeutics Inc. | XenoTherapeutics | 2026-01-28 | $0k | 0.0x | 0.0x |
| Astria Therapeutics | BioCryst Pharmaceuticals | 2026-01-23 | $700m | 0.0x | 0.0x |
| Bluejay Therapeutics | Mirum Pharmaceuticals | 2026-01-23 | $0k | 0.0x | 0.0x |
| Agenus manufacturing operations (Agenus West) | Zydus Lifesciences Limited | 2026-01-15 | $75m | 0.0x | 0.0x |
| Cidara Therapeutics | Merck Sharp & Dohme LLC | 2026-01-07 | $0k | 0.0x | 0.0x |
| Mersana Therapeutics | Day One Biopharmaceuticals | 2026-01-06 | $0k | 0.0x | 0.0x |
| Advanced Biomed (HK) Limited | Wei Ha Hui | 2025-12-23 | $20k | 0.0x | 0.0x |
| Evoke Pharma | QOL Medical | 2025-12-17 | $0k | 0.0x | 0.0x |
| AVM Biotechnology Inc. | AI Technology Group Inc. | 2025-12-15 | $0k | 0.0x | 0.0x |
| Merus N.V. | Genmab A/S | 2025-12-12 | $0k | 0.0x | 0.0x |
| Scorpius Holdings CDMO and R&D assets | Tivic Health Systems | 2025-12-10 | $15m | 0.0x | 0.0x |
| Scorpius Holdings CDMO business | Tivic Health Systems | 2025-12-10 | $0k | 0.0x | 0.0x |
| Adverum Biotechnologies | Eli Lilly and Company | 2025-12-09 | $0k | 0.0x | 0.0x |
| Akero Therapeutics | Novo Nordisk A/S | 2025-12-09 | $0k | 0.0x | 0.0x |
| Orbital Therapeutics | Bristol-Myers Squibb Company | 2025-12-08 | $0k | 0.0x | 0.0x |
| Mural Oncology plc | XOMA Royalty Corporation | 2025-12-05 | $0k | 0.0x | 0.0x |
| LAVA Therapeutics N.V. | XOMA Royalty Corporation | 2025-11-20 | $0k | 0.0x | 0.0x |
| Melt Pharmaceuticals | Harrow | 2025-11-17 | $4m | 0.0x | 0.0x |
| Metsera | Pfizer Inc. | 2025-11-13 | $0k | 0.0x | 0.0x |
| Decoy Therapeutics Inc. | Salarius Pharmaceuticals | 2025-11-12 | $0k | 0.0x | 0.0x |
| Damora Therapeutics | Galecto | 2025-11-10 | $0k | 0.0x | 0.0x |
| Xepi (ozenoxacin) cream product assets | Pelthos Therapeutics Inc. | 2025-11-06 | $3m | 0.0x | 0.0x |
| Beckley Psytech Limited | ATAI Life Sciences N.V. | 2025-11-05 | $0k | 0.0x | 0.0x |
| 89bio, Inc. | Roche Holdings | 2025-10-30 | $0k | 0.0x | 0.0x |
| Tourmaline Bio | Novartis AG | 2025-10-28 | $0k | 0.0x | 0.0x |
| Advent BioServices Ltd. | Northwest Biotherapeutics | 2025-10-24 | $0k | 0.0x | 0.0x |
| MitoCareX Bio Ltd. | N2OFF | 2025-10-20 | $0k | 0.0x | 0.0x |
| ESSA Pharma Inc. | XenoTherapeutics | 2025-10-09 | $0k | 0.0x | 0.0x |
| ABCJ | TransCode Therapeutics | 2025-10-08 | $0k | 0.0x | 0.0x |
| scPharmaceuticals Inc. | MannKind Corporation | 2025-10-07 | $0k | 0.0x | 0.0x |
| Verona Pharma plc | Merck Sharp & Dohme LLC | 2025-10-07 | $0k | 0.0x | 0.0x |
| SKNY Pharmaceuticals | MIRA Pharmaceuticals | 2025-09-29 | $0k | 0.0x | 0.0x |
| Vector Bio Source Inc. | FOXO Technologies Inc. | 2025-09-19 | $0k | 0.0x | 0.0x |
| HilleVax | XOMA Royalty Corporation | 2025-09-17 | $0k | 0.0x | 0.0x |
| Y-mAbs Therapeutics | Perseus BidCo US | 2025-09-16 | $0k | 0.0x | 0.0x |
| DURECT Corporation | Bausch Health Companies Inc. | 2025-09-11 | $0k | 0.0x | 0.0x |
| NKMax Co. | NKGen Biotech | 2025-09-04 | $17m | 0.0x | 0.0x |
| Solventum Purification & Filtration business | Thermo Fisher Scientific Inc. | 2025-09-01 | $4.0bn | 0.0x | 0.0x |
| Antev Ltd. | Medicus Pharma Ltd. | 2025-08-29 | $0k | 0.0x | 0.0x |
| FibroGen International (Hong Kong) Ltd. | AstraZeneca Treasury Limited | 2025-08-29 | $220m | 0.0x | 0.0x |
| iTeos Therapeutics | Concentra Biosciences | 2025-08-29 | $0k | 0.0x | 0.0x |
| Melinta Therapeutics | CorMedix Inc. | 2025-08-29 | $300m | 0.0x | 0.0x |
| Enzo Biochem | Bethpage Parent | 2025-08-20 | $0k | 0.0x | 0.0x |
| CARGO Therapeutics | Concentra Biosciences | 2025-08-19 | $0k | 0.0x | 0.0x |
| JandB Holdings | NeOnc Technologies Holdings | 2025-08-18 | $0k | 0.0x | 0.0x |
| IGM Biosciences | Concentra Biosciences | 2025-08-14 | $0k | 0.0x | 0.0x |
| Turnstone Biologics Corp. | XOMA Royalty Corporation | 2025-08-08 | $0k | 0.0x | 0.0x |
| Vigil Neuroscience | Sanofi | 2025-08-05 | $0k | 0.0x | 0.0x |
| Adaptimmune cell therapy business (TECELRA | US WorldMeds Partners | 2025-07-31 | $55m | 0.0x | 0.0x |
| Endo | Mallinckrodt plc | 2025-07-31 | $0k | 0.0x | 0.0x |
| Verve Therapeutics | Eli Lilly and Company | 2025-07-25 | $0k | 0.0x | 0.0x |
| Elevation Oncology | Concentra Biosciences | 2025-07-23 | $0k | 0.0x | 0.0x |
| Life Molecular Imaging Limited | Lantheus Holdings | 2025-07-21 | $350m | 0.0x | 0.0x |
| Blueprint Medicines Corporation | Sanofi | 2025-07-17 | $9.1bn | 0.0x | 0.0x |
| Akoya Biosciences | Quanterix Corporation | 2025-07-08 | $0k | 0.0x | 0.0x |
| RE Ventures I | Recursion Pharmaceuticals | 2025-07-08 | $8m | 0.0x | 0.0x |
| SpringWorks Therapeutics | Merck KGaA | 2025-07-01 | $0k | 0.0x | 0.0x |
| Kineta | TuHURA Biosciences | 2025-06-30 | $0k | 0.0x | 0.0x |
| European Orladeyo Berotralstat business | Neopharmed Gentili | 2025-06-27 | $264m | 0.0x | 0.0x |
| dne pharma - Business | Navamedic | 2025-06-23 | $27m | 0.0x | 3.6x |
| SomaLogic | Illumina | 2025-06-23 | $350m | 0.0x | 0.0x |
| InfiniClone Limited | Shineco | 2025-06-18 | $0k | 0.0x | 0.0x |
| Agenus - Biologics CMC Facilities | Zydus Lifesciences | 2025-06-03 | $125m | 0.0x | 0.0x |
| bluebird bio | Carlyle and SK Capital Partners | 2025-06-02 | $0k | 0.0x | 0.0x |
| Checkpoint Therapeutics | Sun Pharmaceutical Industries | 2025-05-30 | $28m | 0.0x | 0.0x |
| ACELYRIN | Alumis Inc. | 2025-05-21 | $0k | 0.0x | 0.0x |
| Inozyme Pharma | BioMarin Pharmaceutical | 2025-05-16 | $270m | 0.0x | 0.0x |
| Phytanix Bio | Protagenic Therapeutics | 2025-05-16 | $0k | 0.0x | 0.0x |
| Allakos Inc. | Concentra Biosciences | 2025-05-15 | $0k | 0.0x | 0.0x |
| Kronos Bio | Concentra Biosciences | 2025-05-01 | $35m | 0.0x | 3.6x |
| Regulus Therapeutics | Novartis | 2025-04-30 | $800m | 0.0x | 0.0x |
| UDENYCA franchise | Intas Pharmaceuticals Ltd. | 2025-04-11 | $483m | 0.0x | 0.0x |
| Aadi Sub | Kaken Pharmaceutical | 2025-03-26 | $100m | 0.0x | 0.0x |
| Aadi Subsidiary | Kaken Pharmaceutical Co. | 2025-03-25 | $102m | 0.0x | 0.0x |
| Cyclo Therapeutics | Rafael Holdings | 2025-03-25 | $0k | 0.0x | 0.0x |
| Genetic Networks | Fifty 1 Labs | 2025-03-20 | $10m | 0.0x | 0.0x |
| Emergent BioSolutions - Baltimore-Bayview Drug Substance Manufacturing Site | Syngene International | 2025-03-19 | $37m | 0.0x | 0.0x |
| 2seventy bio | Bristol-Myers Squibb | 2025-03-10 | $286m | 0.0x | 0.0x |
| Checkpoint | Sun Pharma | 2025-03-09 | $355m | 0.0x | 0.0x |
| Chimerix | Jazz Pharmaceuticals | 2025-03-05 | $935m | 0.0x | 0.0x |
| Singular Genomics Systems | Deerfield Management Company | 2025-02-21 | $0k | 0.0x | 0.0x |
| FibroGen China | AstraZeneca | 2025-02-20 | $160m | 0.0x | 0.0x |
| Mayne Pharma | Cosette Pharmaceuticals | 2025-02-20 | $430m | 35.8x | 1.7x |
| Marinus Pharmaceuticals | Immedica Pharma AB | 2025-02-11 | $0k | 0.0x | 0.0x |
| Revance Therapeutics | Crown Laboratories | 2025-02-06 | $0k | 0.0x | 0.0x |
| Avid Bioservices | GHO Capital Partners LLP and Ampersand Capital Partners | 2025-02-05 | $0k | 0.0x | 0.0x |
| SeQure Dx | MaxCyte | 2025-01-30 | $5m | 0.0x | 0.0x |
| Evergreen Theragnostics | Lantheus Medical Imaging | 2025-01-28 | $250m | 0.0x | 0.0x |
| Life Molecular | Lantheus Medical Imaging | 2025-01-13 | $350m | 0.0x | 0.0x |
| Emission Inc. | Quanterix Corporation | 2025-01-08 | $10m | 0.0x | 0.0x |
| Poseida Therapeutics | Roche Holdings | 2025-01-08 | $0k | 0.0x | 0.0x |
| Marinus | Immedica Pharma | 2024-12-30 | $151m | 0.0x | 4.9x |
| RLS Radiopharmacies | Telix Pharmaceuticals Ltd. | 2024-12-23 | $230m | 0.0x | 0.0x |
| Increlex product line | Eton Pharmaceuticals | 2024-12-19 | $0k | 0.0x | 0.0x |
| MediPharm Labs - Napanee Facility | Kensana Health | 2024-12-17 | $6m | 0.0x | 0.0x |
The 150 most recent of 743 recorded transactions in this sector. n/d means not disclosed. Most transactions close without a published multiple, which is why the disclosed count matters more than the median.
See all 743 Life Science transactions
Who owns Healthcare & Life Sciences companies
On PEStore, Life Science sits within Healthcare & Life Sciences. PEStore profiles the private equity firms and serial acquirers active there: what they own, how long they have held it, and every deal on record. Underlined acquirers above link to their profiles.
Healthcare & Life Sciences investors and acquirers on PEStoreMultiples across every sector
What is your Life Science business worth?
Run the free valuation against the current multiple band for your sector. It takes about a minute and shows the range and the method behind it.
Run a valuation